Qiagen's Germantown Plant Operational

Published March 2002

GERMANTOWN, MD. -

Dutch firm Qiagen's 200,000-sf Germantown manufacturing facility and U.S. headquarters will be operational in late February 2002 after two years of construction. The biotech firm plans to hire 300 employees, one-third of whom will work in R&D operations and two-thirds in manufacturing. Qiagen Sciences, Qiagen's U.S. subsidiary, makes products and tools for life science research.

Copyright 2008 Tradeline Inc.
All Rights Reserved
ISSN: 1096-4894